Hiasa, Yoichi

Publishing since 1966 (Dinosaur)

Has published 216 publications in 45 years

Number of publications published per year by Hiasa, Yoichi. (Source : PubMed)

Distribution of publications types for Hiasa, Yoichi. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Michitaka K, Hiraoka A, Kume M, Uehara T, Hidaka S, Ninomiya T, Hasebe A, Miyamoto Y, Ichiryu M, Tanihira T, Nakahara H, Ochi H, Tanabe A, Uesugi K, Tokumoto Y, Mashiba T, Abe M, Hiasa Y, Matsuura B, Onji M. Amino acid imbalance in patients with chronic liver diseases.  Hepatol. Res.  2010  
•  Miyake T, Akbar SM, Yoshida O, Chen S, Hiasa Y, Matsuura B, Abe M, Onji M. Impaired dendritic cell functions disrupt antigen-specific adaptive immune responses in mice with nonalcoholic fatty liver disease.  J. Gastroenterol.  2010  
•  Hirooka M, Koizumi Y, Kisaka Y, Abe M, Murakami H, Matsuura B, Hiasa Y, Onji M. Mass reduction by radiofrequency ablation before hepatic arterial infusion chemotherapy improved prognosis for patients with huge hepatocellular carcinoma and portal vein thrombus.  AJR Am J Roentgenol  2010;194;2  
•  Hiraoka A, Hirooka M, Koizumi Y, Hidaka S, Uehara T, Ichikawa S, Hasebe A, Miyamoto Y, Ninomiya T, Michitaka K, Horiike N, Yamashita Y, Hiasa Y, Matsuura B, Onji M. Modified technique for determining therapeutic response to radiofrequency ablation therapy for hepatocellular carcinoma using US-volume system.  Oncol. Rep.  2010;23;2  
•  Hiraoka A, Michitaka K, Horiike N, Hidaka S, Uehara T, Ichikawa S, Hasebe A, Miyamoto Y, Ninomiya T, Sogabe I, Ishimaru Y, Kawasaki H, Koizumi Y, Hirooka M, Yamashita Y, Abe M, Hiasa Y, Matsuura B, Onji M. Radiofrequency ablation therapy for hepatocellular carcinoma in elderly patients.  J. Gastroenterol. Hepatol.  2010;25;2  
•  Miyaoka H, Uesugi K, Shigematsu S, Miyake T, Furukawa E, Okita S, Okada T, Abe M, Murakami H, Matsuura B, Hiasa Y, Onji M. Clinical course of tuberculous peritonitis determined by laparoscopy.  Intern. Med.  2010;49;4  
•  Michitaka K, Nishiguchi S, Aoyagi Y, Hiasa Y, Tokumoto Y, Onji M. Etiology of liver cirrhosis in Japan: a nationwide survey.  J. Gastroenterol.  2010;45;1  
•  Tanaka Y, Nishida N, Sugiyama M, Kurosaki M, Matsuura K, Sakamoto N, Nakagawa M, Korenaga M, Hino K, Hige S, Ito Y, Mita E, Tanaka E, Mochida S, Murawaki Y, Honda M, Sakai A, Hiasa Y, Nishiguchi S, Koike A, Sakaida I, Imamura M, Ito K, Yano K, Masaki N, Sugauchi F, Izumi N, Tokunaga K, Mizokami M. Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C.  Nat. Genet.  2009;41;10  
•  Uehara T, Hirooka M, Kisaka Y, Abe M, Hiasa Y, Onji M. Usefulness of the hyperechoic rim for assessing the therapeutic efficacy of radiofrequency ablation in hepatocellular carcinoma patients.  Hepatol. Res.  2009;39;10  
•  Tamura Y, Igarashi M, Suda T, Wakai T, Shirai Y, Umemura T, Tanaka E, Kakizaki S, Takagi H, Hiasa Y, Onji M, Aoyagi Y. Fucosylated Fraction of Alpha-Fetoprotein as a Predictor of Prognosis in Patients with Hepatocellular Carcinoma After Curative Treatment.  Dig. Dis. Sci.  2009  

[ See timeline ] [ See all publications ]